[go: up one dir, main page]

FI962948L - Method for dissolving poorly soluble pharmaceutically active substances - Google Patents

Method for dissolving poorly soluble pharmaceutically active substances Download PDF

Info

Publication number
FI962948L
FI962948L FI962948A FI962948A FI962948L FI 962948 L FI962948 L FI 962948L FI 962948 A FI962948 A FI 962948A FI 962948 A FI962948 A FI 962948A FI 962948 L FI962948 L FI 962948L
Authority
FI
Finland
Prior art keywords
active substances
pharmaceutically active
poorly soluble
soluble pharmaceutically
dissolving poorly
Prior art date
Application number
FI962948A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI962948A7 (en
FI962948A0 (en
Inventor
Dadi Jamshed Dhabhar
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of FI962948L publication Critical patent/FI962948L/en
Publication of FI962948A7 publication Critical patent/FI962948A7/en
Publication of FI962948A0 publication Critical patent/FI962948A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI962948A 1994-01-24 1995-01-24 Process for dissolving difficult soluble pharmaceutically active substances FI962948A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18557694A 1994-01-24 1994-01-24
PCT/US1995/001018 WO1995019759A1 (en) 1994-01-24 1995-01-24 Process for solubilizing difficultly soluble pharmaceutical actives

Publications (3)

Publication Number Publication Date
FI962948L true FI962948L (en) 1996-07-23
FI962948A7 FI962948A7 (en) 1996-07-23
FI962948A0 FI962948A0 (en) 1996-07-23

Family

ID=22681571

Family Applications (1)

Application Number Title Priority Date Filing Date
FI962948A FI962948A0 (en) 1994-01-24 1995-01-24 Process for dissolving difficult soluble pharmaceutically active substances

Country Status (14)

Country Link
EP (1) EP0741560A1 (en)
JP (1) JPH09508128A (en)
CN (1) CN1138827A (en)
AU (1) AU706890B2 (en)
BR (1) BR9506564A (en)
CA (1) CA2181241C (en)
CZ (1) CZ210496A3 (en)
FI (1) FI962948A0 (en)
MX (1) MX9602955A (en)
NO (1) NO963052L (en)
NZ (1) NZ279443A (en)
PL (1) PL315635A1 (en)
SK (1) SK96196A3 (en)
WO (1) WO1995019759A1 (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA975444B (en) * 1996-06-20 1998-12-21 Mcneil Ppc Inc Acetaminophen and meclizine hydrochloride analgesics
WO1998058637A1 (en) * 1996-06-20 1998-12-30 Mcneil-Ppc Acetaminophen and diphenhydramine analgesics
FR2751875B1 (en) * 1996-08-05 1998-12-24 Scr Newpharm NOVEL STABLE LIQUID FORMULATIONS BASED ON PARACETAMOL AND THEIR METHOD OF PREPARATION
US5763449A (en) * 1996-08-07 1998-06-09 Ascent Pediatrics, Inc. Pleasant-tasting aqueous liquid composition of a bitter-tasting drug
US6365180B1 (en) * 1998-01-20 2002-04-02 Glenn A. Meyer Oral liquid compositions
ATE429210T1 (en) * 1998-01-20 2009-05-15 Applied Analytical Ind Inc ORAL LIQUID COMPOSITIONS
US20020082307A1 (en) * 1999-01-11 2002-06-27 Dobrozsi Douglas Joseph Compositions having improved stability
US20020086878A1 (en) * 1999-01-11 2002-07-04 Douglas Joseph Dobrozsi Compositions having improved stability
US6846495B2 (en) 1999-01-11 2005-01-25 The Procter & Gamble Company Compositions having improved delivery of actives
US6211246B1 (en) * 1999-06-10 2001-04-03 Mcneil-Ppc, Inc. Rapidly absorbed liquid compositions
FR2796843B1 (en) * 1999-07-29 2003-05-09 So Ge Val Sa CONCENTRATED AND STABILIZED ANTIPYRETIC COMPOSITION FOR VETERINARY USE INTENDED TO BE INCORPORATED IN ANIMAL FEEDING AS WELL AS A METHOD OF INCORPORATING THIS COMPOSITION INTO ANIMAL BEVERAGE WATER
US6251426B1 (en) 1999-09-02 2001-06-26 Banner Pharmacaps, Inc. Ibuprofen-containing softgels
DE10011032A1 (en) * 2000-03-07 2001-09-13 Bayer Ag Stable solutions of acetylsalicylic acid in mixture of organic solvent and water, useful for topical treatment of pain, especially pain associated with herpes zoster
KR20020069387A (en) * 2001-02-26 2002-09-04 진양제약주식회사 Mixing method of composition containing doxylamine succinate and soft capsule preparation containing the composition
WO2003011306A1 (en) * 2001-07-31 2003-02-13 Wyeth Sucralose formulations to mask unpleasant tastes
US7101572B2 (en) * 2001-12-07 2006-09-05 Unilab Pharmatech, Ltd. Taste masked aqueous liquid pharmaceutical composition
CN100379406C (en) * 2003-09-22 2008-04-09 北京德众万全药物技术开发有限公司 Method for preparing tiny pellets of difficult soluble drugs and formulation containing the pellets
JP5406530B2 (en) * 2005-10-26 2014-02-05 バナー ファーマキャプス， インコーポレイテッド Dual controlled release matrix system based on hydrophilic vehicle
DE102005053066A1 (en) 2005-11-04 2007-05-10 Basf Ag Use of copolymers as solubilizers for sparingly water-soluble compounds
JP2009523119A (en) * 2005-12-09 2009-06-18 ビーエーエスエフ ソシエタス・ヨーロピア Use of polyvinyl lactam-polyoxyalkylene block copolymers as solubilizers for compounds that are poorly soluble in water
US8637076B2 (en) 2006-06-01 2014-01-28 Cima Labs Inc. Prednisolone salt formulations
JP2008184430A (en) * 2007-01-30 2008-08-14 Ss Pharmaceut Co Ltd Soft capsule
CA2690490C (en) * 2010-01-19 2012-06-26 Accucaps Industries Limited Pharmaceutical formulations of loratadine for encapsulation and combinations thereof
CA2690488C (en) * 2010-01-19 2013-06-11 Accucaps Industries Limited Pharmaceutical formulations of naproxen for soft gel encapsulation and combinations thereof
EP3895694A1 (en) 2010-01-28 2021-10-20 Eagle Pharmaceuticals, Inc. Formulations of bendamustine
RS58744B1 (en) 2012-03-20 2019-06-28 Eagle Pharmaceuticals Inc Liquid composition for use in a method of treating bendamustine-responsive conditions in patients requiring reduced volumes for administration
DK2827862T3 (en) 2012-03-20 2024-02-12 Eagle Pharmaceuticals Inc FORMULATIONS OF BENDAMUSTINE
RU2015137145A (en) 2013-02-28 2017-04-03 Пфайзер Инк. NEW LIQUID COMPOSITIONS WITH INCREASED STABILITY
GB201506755D0 (en) * 2015-04-21 2015-06-03 Reckitt Benckiser Llc Novel pharmaceutical formulation
TWI586379B (en) 2015-06-29 2017-06-11 永信藥品工業股份有限公司 Method of preparing very slightly soluble drug with solid dosage form
EP3364955B1 (en) 2015-10-09 2022-04-20 RB Health (US) LLC Pharmaceutical formulation
CN115957194B (en) * 2021-10-08 2025-05-16 人福普克药业（武汉）有限公司 Solvent system for content in cold soft capsule and cold soft capsule

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5141961A (en) * 1991-06-27 1992-08-25 Richrdson-Vicks Inc. Process for solubilizing difficulty soluble pharmaceutical actives

Also Published As

Publication number Publication date
CA2181241A1 (en) 1995-07-27
AU1607595A (en) 1995-08-08
SK96196A3 (en) 1997-03-05
NO963052D0 (en) 1996-07-22
EP0741560A1 (en) 1996-11-13
PL315635A1 (en) 1996-11-25
NZ279443A (en) 1998-04-27
CZ210496A3 (en) 1996-12-11
BR9506564A (en) 1997-09-02
WO1995019759A1 (en) 1995-07-27
FI962948A7 (en) 1996-07-23
CN1138827A (en) 1996-12-25
NO963052L (en) 1996-09-24
AU706890B2 (en) 1999-07-01
MX9602955A (en) 1997-06-28
CA2181241C (en) 2000-04-25
JPH09508128A (en) 1997-08-19
FI962948A0 (en) 1996-07-23

Similar Documents

Publication Publication Date Title
FI962948L (en) Method for dissolving poorly soluble pharmaceutically active substances
FI960042L (en) Pharmaceutical preparations for poorly soluble active substances
FI963045L (en) Pharmaceutically active compounds and liposomes and method for using them
FI973320A7 (en) Solid active ingredient-containing preparations
FI952033L (en) Pharmacologically active pyrrolopyrimidine derivatives
NO961136D0 (en) Pharmaceutical formulation basis for nano-suspensions
FI944602A7 (en) Pharmaceutically active bicyclic-heterocyclic amines
EE9800116A (en) Pharmaceutically active quinazoline compounds
FI973733L (en) Pharmaceutical preparation and method for its preparation
EE200000480A (en) Apparatus and method for indicating administration
ATE187063T1 (en) DRUG
NO20003721D0 (en) Pharmaceutically active morpholinol
DE69525148D1 (en) PHARMACEUTICAL FORMULATION
FI946173L (en) Method for improving drug delivery efficiency using modified saponins
FI932553A7 (en) New pharmaceutical formulations containing a pharmacologically active ionizable substance and a method for their preparation
FI924642L (en) Method for preparing therapeutically active 3-indolylthioacetate derivatives
DE69528843D1 (en) PHARMACOLOGICALLY ACTIVE 2-MERCAPTOBENZIMIDAZOLE DERIVATIVES
FI103744B1 (en) Method and arrangement for calibrating the active filter
EE9400296A (en) Piperidinylthioindole derivatives, dosage forms, active analgesic, methods for their preparation
IT1273469B (en) LATERAL UPRIGHT FOR FRAMEWORK OF HOSES
NO940844D0 (en) Pharmaceutically active hydroxycarboxylic acid derivatives
ATE244246T1 (en) PYRIDOTHIENODIAZEPINES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING SAME
FI973230L (en) New pharmaceutical formulation
EP0923564A4 (en) PHARMACEUTICAL COMPOUNDS
NO971879D0 (en) Preparation for transdermal administration